Advanced MRI Findings in Medulloblastomas: Relationship to Genetic Subtypes, Histopathology, and Immunohistochemistry
- PMID: 33465267
- DOI: 10.1111/jon.12831
Advanced MRI Findings in Medulloblastomas: Relationship to Genetic Subtypes, Histopathology, and Immunohistochemistry
Abstract
Background and purpose: For diagnosis of medulloblastoma, the updated World Health Organization classification now demands for genetic typing, defining more precisely the tumor biology, therapy, and prognosis. We investigated potential associations between magnetic resonance imaging (MRI) parameters including apparent diffusion coefficient (ADC) and neuropathologic features of medulloblastoma, focusing on genetic subtypes.
Methods: This study was a retrospective single-center analysis of 32 patients (eight females, median age = 9 years [range, 1-57], mean 12.6 ± 11.3) from 2012 to 2019. Genetic subtypes (wingless [WNT]; sonic hedgehog [SHH]; non-WNT/non-SHH), histopathology, immunohistochemistry (p53, Ki67), and the following MRI parameters were correlated: tumor volume, location (midline, pontocerebellar, and cerebellar hemisphere), edema, hydrocephalus, metastatic disease (presence/absence and each), contrast-enhancement (minor, moderate, and distinct), cysts (none, small, and large), hemorrhage (none, minor, and major), and ADCmean . The ADCmean was calculated using manually set regions of interest within the solid tumor. Statistics comprised univariate and multivariate testing.
Results: Out of 32 tumors, three tumors were WNT activated (9.4%), 13 (40.6%) SHH activated, and 16 (50.0%) non-WNT/non-SHH. Hemispherical location (n = 7/8, P = .003) and presence of edema (8/8; P < .001, specificity 100%, positive predictive value 100%) were significantly associated with SHH activation. The combined parameter "no edema + no metastatic disease + cysts" significantly discriminated WNT-activated from SHH-activated medulloblastoma (P = .036). ADCmean (10-6 mm2 /s) was 484 for WNT-activated, 566 for SHH-activated, and 624 for non-WNT/non-SHH subtypes (P = .080). A significant negative correlation was found between ADCmean and Ki67 (r = -.364, P = .040).
Conclusion: MRI analysis enabled noninvasive differentiation of SHH-activated medulloblastoma. ADC alone was not reliable for genetic characterization, but associated with tumor proliferation rate.
Keywords: Apparent diffusion coefficient; diffusion-weighted imaging; medulloblastoma; molecular groups; posterior fossa tumors.
© 2021 The Authors. Journal of Neuroimaging published by Wiley Periodicals LLC on behalf of American Society of Neuroimaging.
Similar articles
-
Association of imaging biomarkers with molecular subtypes of medulloblastoma.Neuroradiol J. 2025 Jun;38(3):304-311. doi: 10.1177/19714009241303065. Epub 2024 Nov 25. Neuroradiol J. 2025. PMID: 39586576 Free PMC article.
-
Pediatric Posterior Fossa Medulloblastoma: The Role of Diffusion Imaging in Identifying Molecular Groups.J Neuroimaging. 2020 Jul;30(4):503-511. doi: 10.1111/jon.12704. Epub 2020 Jun 12. J Neuroimaging. 2020. PMID: 32529709
-
Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype.AJNR Am J Neuroradiol. 2017 Oct;38(10):1892-1898. doi: 10.3174/ajnr.A5313. Epub 2017 Aug 10. AJNR Am J Neuroradiol. 2017. PMID: 28798218 Free PMC article.
-
Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.Childs Nerv Syst. 2018 May;34(5):809-815. doi: 10.1007/s00381-018-3765-2. Epub 2018 Mar 26. Childs Nerv Syst. 2018. PMID: 29582169 Review.
-
Genetic Markers as Predictors for Response to Treatment and Possible Therapeutic Targets in Medulloblastoma.CNS Neurol Disord Drug Targets. 2023;22(5):634-642. doi: 10.2174/1871527321666220509141030. CNS Neurol Disord Drug Targets. 2023. PMID: 35579144 Review.
Cited by
-
The 2021 World Health Organization Classification of Tumors of the Central Nervous System: What Neuroradiologists Need to Know.AJNR Am J Neuroradiol. 2022 Jul;43(7):928-937. doi: 10.3174/ajnr.A7462. Epub 2022 Jun 16. AJNR Am J Neuroradiol. 2022. PMID: 35710121 Free PMC article. Review.
-
Prognostic role of NLGN2 and PTGDS in medulloblastoma based on gene expression omnibus.Am J Transl Res. 2022 Jun 15;14(6):3769-3782. eCollection 2022. Am J Transl Res. 2022. PMID: 35836891 Free PMC article.
-
The role of apparent diffusion coefficient histogram metrics for differentiating pediatric medulloblastoma histological variants and molecular groups.Pediatr Radiol. 2022 Dec;52(13):2595-2609. doi: 10.1007/s00247-022-05411-w. Epub 2022 Jul 8. Pediatr Radiol. 2022. PMID: 35798974
-
Shunt dependency in supratentorial intraventricular tumors depends on the extent of tumor resection.Acta Neurochir (Wien). 2023 Apr;165(4):1053-1064. doi: 10.1007/s00701-023-05532-7. Epub 2023 Mar 2. Acta Neurochir (Wien). 2023. PMID: 36862214 Free PMC article.
-
Medulloblastomas, CNS embryonal tumors, and cerebellar mutism syndrome: advances in care and future directions.Childs Nerv Syst. 2023 Oct;39(10):2633-2647. doi: 10.1007/s00381-023-06112-x. Epub 2023 Aug 26. Childs Nerv Syst. 2023. PMID: 37632526 Review.
References
-
- Partap S, Curran EK, Propp JM, et al. Medulloblastoma incidence has not changed over time: a CBTRUS study. J Pediatr Hematol Oncol 2009;31:970-1.
-
- Menyhárt O, Győrffy B. Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches. Cancer Metastasis Rev 2020;39:211-33.
-
- Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016;131:803-20.
-
- Pickles JC, Hawkins C, Pietsch T, et al. CNS embryonal tumours: WHO 2016 and beyond. Neuropathol Appl Neurobiol 2018;44:151-62.
-
- Zhukova N, Ramaswamy V, Remke M, et al. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol 2013;31:2927-35.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous